Tagged: alpha tau medical

OurCrowd Portfolio Company Alpha Tau Medical Seeks New Cancer Treatment, Shares Results of Trial Radiotherapy

OurCrowd portfolio company Alpha Tau Medical is an Israeli medical device company that focuses on research, development and commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv… Read More

Following OurCrowd Investment, Alpha Tau Medical Launches Clinical Trials for “Breakthrough” Treatment

Alpha Tau Medical

Alpha Tau Medical, developer of a breakthrough alpha-radiation cancer therapy, has initiated new clinical trials evaluating the efficacy of their Alpha DaRT  or “Dіffusіng Alpha-emitters Radіatіon Therapy” with two leading medical centers in Rome, Italy. “Building on our recent successful round of $29 Million in… Read More

Cancer Therapy Medtech Alpha Tau Medical Raises $29 Million Backed by OurCrowd

Alpha Tau Medical

Israeli Medtech start-up, Alpha Tau Medical, has raised $29 million to accelerate its promising cancer treatment Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy). The treatment is being described as a “breakthrough cancer treatment,” that delivers high-precision alpha radiation, that is released when radioactive substances decay inside the… Read More

Send this to a friend